Taking advantage of the distinct markers used for Jurkat-S(Wuhan) and Jurkat-S(Alpha) cells (EGFR and EGFP, respectively), we could mix equal numbers of both cell lines and incubate the cell mixture with dilutions of sera from patients recovered from infection with SARS-CoV-2 or vaccinated. The gene discussed is EGFR; the disease is infection.